Aprea Therapeutics, Inc. (APRE) Insider Trading

Name: Aprea Therapeutics, Inc. (APRE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 17, 2026): Grissinger Michael (Director): Grant/Award of 3,135 shares.

Get alerted when insiders trade APRE

Email address

Loading company data...

Beta

Loading company details...

Beta